Hypertension and dyslipidemia therapeutics tutorial Flashcards

1
Q

Beta-blockers are first-choice in the management of hypertension. T/F

A

False

  • -Beta-blockers are no longer first choice medication for hypertension
  • -Starting a smoking patient with wheeze on a beta-blocker (albeit a beta 1 selective agent) is questionable and should have prompted revaluation when symptoms occurred.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the isolated systolic hypertension?

A

A form of hypertension that is characterized by elevated systolic BP and normal diastolic BP (and widened pulse pressure). It most commonly occurs in the elderly population because of a decrease in arterial compliance. It may also occur due to an increase in cardiac output (e.g., anemia, hyperthyroidism, aortic insufficiency, AV fistula). It is associated with an increased risk of cardiovascular events (MI, stroke, renal dysfunction).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the white coat hypertension?

A
  • -Definition: arterial hypertension detected only in clinical settings or during blood pressure measurement at a physician’s practice
  • -Etiology: anxiety experienced by the patient
  • -Clinical features: consistently normal blood pressure measurements and normalization of elevated blood pressure outside of a clinical setting
  • -Diagnostics: 24-hour blood pressure monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the primary (essential) hypertension?

A
  • -No specific cause; multifactorial etiology including epigenetic/genetic and environmental factors
  • -Accounts for 85–95% of cases of hypertension in adults
  • -Accounts for 15–20% of cases of hypertension in children < 12 years of age
  • -Age at onset: 25–55 years (prevalence is increasing in adolescents)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is secondary hypertension?

A
  • -Caused by an identifiable underlying condition
  • -Accounts for 5–15% of cases of hypertension in adults
  • -Accounts for 70–85% of cases of hypertension in children < 12 years of age
  • -Age at onset < 25 years or > 55 years
  • -RECENT can help you remember the causes of secondary hypertension: R = Renal (e.g., renal artery stenosis, glomerulonephritis), E = Endocrine (e.g., Cushing syndrome, hyperthyroidism, Conn syndrome), C = Coarctation of aorta, E = Estrogen (oral contraceptives), N = Neurologic (raised intracranial pressure, psychostimulants use), T = Treatment (e.g., glucocorticoids, NSAIDs).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the endocrine causes of secondary hypertension?

A
  • -Primary hyperaldosteronism (Conn syndrome): most common cause of secondary hypertension in adults
  • -Hypercortisolism (Cushing syndrome)
  • -Hyperthyroidism
  • -Pheochromocytoma
  • -Primary hyperparathyroidism
  • -Acromegaly
  • -Congenital adrenal hyperplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the renal causes of secondary hypertension?

A
  • -Renovascular hypertension (e.g., due to renal artery stenosis)
  • -Polycystic kidney disease (ADPKD)
  • -Renal failure (renal parenchymal hypertension)
  • -Glomerulonephritis
  • -Systemic lupus erythematosus
  • -Renal tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

other causes of secondary hypertension except renal and endocrine??

A
  • -Coarctation of the aorta
  • -Obstructive sleep apnea
  • -Medication: sympathomimetic drugs, corticosteroids, –NSAIDs, oral contraceptives
  • -Recreational drug use: amphetamines, cocaine, phencyclidine
  • -Isolated systolic hypertension:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the coarctation of the aorta?

A

A congenital heart defect that involves the narrowing of the aorta at the aortic isthmus. Frequently associated with other congenital heart defects (e.g., bicuspid aortic valve, VSD and/or PDA) and Turner syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the pathophysiology of aortic coarctation?

A

1) Genetic defects and/or intrauterine ischemia → medial thickening and intimal hyperplasia form a ridge encircling the aortic lumen → narrowing of the aorta → ↑ flow proximal and ↓ flow distal to the narrowing
2) Compensatory mechanisms
- -Myocardial hypertrophy and collateral blood flow (e.g., intercostal vessels , scapular vessels) develop in cases of discrete stenosis to compensate for the left ventricular outflow tract obstruction (common) → onset of symptoms usually later in childhood
- -In long segment stenosis, there is no time for development of compensatory mechanisms → closure of PDA after birth → left ventricular pressure and volume overload → hypoperfusion of organs and extremities distal to the stenosis, heart failure, cardiogenic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the clinical features of aortic coarctation in adults?

A
  • -Hypertension
  • -Variability in blood pressure in the upper and lower extremities
  • -Headache, epistaxis, tinnitus (Caused by brachiocephalic hypertension)
  • -Claudication of the lower extremities with exertion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how aortic coarctation is diagnosed?

A

1) Best initial test: upper and lower extremity blood pressure measurement and search for brachial-femoral delay
2) Pulse oximetry: ↓ SpO2
3) Echocardiography with doppler (confirmatory test): location and extent of stenosis; concurrent anomalies
4) X-ray
- -Cardiomegaly and ↑ pulmonary vascular markings
- -“Figure of 3” sign (Also referred to as hourglass-like narrowing of the aorta; caused by pre- and postdilatation of the aorta with an indentation at the site of coarctation.)
- -Rib notching (on inferior border of the ribs)
5) Genetic testing for Turner syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the reason of rib notching in aortic coarctation?

A

Internal thoracic and intercostal arteries dilate and form collaterals in cases of aortic narrowing. The increased perfusion leads to pressure atrophy and resorption of the neighboring ribs, which may be visible in chest x-rays as inferior rib notching. This is a finding of chronic disease, commonly observed in children aged > 5 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the lifestyle factors that increase BP?

A
  • -Salt –Salt added at table and in the cooking. Much processed foods eaten.
  • -Calories–Excess calories and BMI 29 kg/m2
  • -Alcohol intake
  • -lack of exercise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the signs of end-organ damage in hypertension?

A

1) cardiac
- -Congestive heart failure, dilated cardiomyopathy, hypertrophic cardiomyopathy
- -Coronary artery disease and myocardial infarction
- -Atrial fibrillation
- -Aortic aneurysm
- -Aortic dissection
- -Carotid artery stenosis
- -Peripheral artery disease
- -Atherosclerosis
2) Brain
- -Stroke , TIA
- -Cognitive changes such as memory loss
3) Hypertensive nephrosclerosis
- -Pathophysiology: chronic hypertension → narrowing of afferent arterioles and efferent arterioles → reduction of glomerular blood flow → glomerular and tubular ischemia → arteriolonephrosclerosis and fibrosis (focal segmental glomerulosclerosis) → end-stage renal disease
- -Typical findings
- -Initially microalbuminuria and microhematuria
- -With disease progression, nephrosclerosis with macroalbuminuria (usually < 1 g/day) and progressive renal failure occur.
4) Eyes
- -Hypertensive retinopathy
- -Fundoscopic examination:
- -Cotton-wool spots
- -Retinal hemorrhages (i.e., flame-shaped hemorrhages)
- -Microaneurysms
- -Arteriovenous nicking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The lifestyle measures that are widely recognized to lower BP and cholesterol and/or cardiovascular risk are:

A

1) Smoking cessation (reduces CV risk)
2) Diet
- -Weight reduction through decreased calorie intake
- -Reduction of salt intake
- -Increase in fruit & vegetable intake,
- -Decrease in saturated & total fat intake
3) Reduction of excessive alcohol intake
4) Greater physical exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the signs of eye damage in hypertension?

A

1) Hypertensive retinopathy
- -Arteriosclerotic and hypertension-related changes of the retinal vessels
- -Fundoscopic examination:
* Cotton-wool spots
* Retinal hemorrhages (i.e., flame-shaped hemorrhages)
* Microaneurysms
* Macular star (results from exudation into the macula)
* Arteriovenous nicking
* Marked swelling and prominence of the optic disk with indistinct borders due to papilledema and optic atrophy (end-stage disease)
2) Presence of papilledema in a hypertensive patient may indicate a hypertensive crisis and warrants urgent lowering of the blood pressure (see hypertensive crises)

18
Q

what are the kidney damage findings due to hypertension?

A
  • -Initially microalbuminuria and microhematuria
  • -With disease progression, nephrosclerosis with macroalbuminuria (usually < 1 g/day) and progressive renal failure occur.
  • -Biopsy: sclerosis in capillary tufts, arterial hyalinosis (By comparison, typical findings in diabetic nephropathy include a thick basement membrane, an increased mesangial matrix, fibrosis, and round nodules within the glomeruli (Kimmelstiel-Wilson nodules.))
19
Q

what are the drug therapies used in hypertensive patients?

A

1) Anti-hypertensive drugs (immediate)
2) Other vascular protective agents as appropriate
- -Lipid lowering agents (immediate or delayed)
- -Hypoglycaemic agents
- -Anti-thrombotic / Anti-platelet drugs
- -Anti-obesity agents
- -Nicotine replacement therapy (delayed)

20
Q

When considering the commencement of anti-hypertensive drug therapy what should be considered?

A
  • -BP level and
  • -Presence of TOD (target organ damage)
  • -Overall cardiovascular risk
21
Q

what is the first choice of antihypertensive drug in a patient with htn?

A
  • -Non-African American patients (including individuals with diabetes): thiazide-type diuretic, calcium channel blocker (CCB), angiotensin-converting enzyme inhibitor (ACE-I), or angiotensin receptor blocker (ARB)
  • -African American patients (including individuals with diabetes): thiazide-type diuretic or CCB (Since salt-sensitive hypertension is more common in African Americans, thiazide diuretics are generally recommended as the initial drug of choice.)
  • -In adults with chronic kidney disease: initial (or add-on) treatment should include an ACE inhibitor or ARB to improve kidney outcome.
22
Q

Given the level of patients’ BP (170/100), it is very likely that he would rapidly move to dual therapy and a which drug would be added to the ACEI or ARB

A

CCB

23
Q

what to consider in deciding the choice of anti-hypertensive drugs?

A

1) Previous treatment – efficacy and side effects
2) Duration of action
- -Once-a-day drugs improves compliance
3) Age and Race
4) Coincidental disease
- -Two for the price of one
5) Contraindications
6) Pregnancy and childbearing potential
7) Cost

24
Q

which anti-hypertensive drug is CI in a patient with Hx of angioedema?

A

ACEI

25
Q

which anti-hypertensive drug is CI in a patient with Hx of depression?

A

Central sympathophlegic (Methyldopa)

26
Q

which anti-hypertensive drug is CI in a patient with Hx of gout?

A

Thiazide-like diuretic (Hydrochlorthiazide)

27
Q

which anti-hypertensive drug is CI in a patient with Hx of grade 2 hearth block?

A

Beta-blocker (Bisoprolol)

28
Q

which anti-hypertensive drug is CI in a patient with gynecomastia?

A

Aldosterone antagonist (Spironolactone)

29
Q

which anti-hypertensive drug is CI in a patient with Hx asthma?

A

beta-blocker

30
Q

what are the CIs of CCBs?

A
  • -A-V block (grade 2 or 3)

- -Heart failure

31
Q

what are the CIs of ACEIs?

A

Pregnancy
Angioneurotic oedema
Hyperkalaemia
Bilateral renal artery stenosis

32
Q

What drug treatments are available for dyslipidemia?

A
  • -HMG-CoA Reductase Inhibitors - Statins
  • -Fibrates – Gemfibrozil, Fenofibrate
  • -Bile Acid Binding Resins - Cholestryramine
  • -Nicotinic Acid
  • -Cholesterol Absorption Inhibitors – Ezetimibe
  • -Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors
33
Q

examples of HMG-CoA inhibitors?

A

Simvastatin, Pravastatin, Lovastatin, Atorvastatin, Fluvastatin, Cerivastatin

34
Q

what is the MOA of HMG-CoA inhibitors?

A
  • -Inhibition of HMG Co A Reductase, the rate limiting enzyme in cholesterol synthesis.
  • -Decreased hepatic synthesis of cholesterol leading to increased expression of LDL receptors and thus increased clearance of LDL
  • -Small reduction in triglycerides and a small increase in HDL-cholesterol
35
Q

what are the side effects of statins?

A

1) GI upset
2) Hepatitis
3) Myopathy -Muscle aches
4) Myositis / Rhadomyalysis
5) Angio-oedema
6) Sleep disturbance
7) Generally well tolerated
- -Serious adverse effects more likely with
- -High doses of potent statins
- -Significant liver disease
- -Co-prescription with a fibrate

36
Q

what is the MOA of fibrates?

A
  • -Mechanism of action: activation of the peroxisome proliferator-activated receptor alpha (PPAR–α) → ↑ lipoprotein lipase activity → ↓ LDL, ↑ HDL, ↓↓↓ triglyceride
  • -Increased lipoprotein lipase activity results in a more rapid degradation of LDL and triglycerides.
37
Q

examples of fibrates?

A

bezafibrate, fenofibrate, and gemfibrozil

38
Q

what are the side effects of fibrates?

A
  • -Dyspepsia
  • -Myopathy
  • -Cholelithiasis
  • -Fibrates inhibit cholesterol 7α hydroxylase → decreased bile acid synthesis → supersaturation of bile with cholesterol (↑ cholesterol:bile acid ratio)
  • -↑ LFTs
39
Q

what are the bile acid resins?

A

1) Drugs: cholestyramine, colestipol, colesevelam
2) Mechanism of action
- -Ion exchange resin binds bile acids in the intestine → interruption of enterohepatic circulation (↓ bile acid absorption and ↑ bile acid excretion) → lowers cholesterol pool and promotes synthesis of LDL receptors (↓ unbound LDL), slightly ↑ HDL, and slightly ↑ triglycerides
3) Side effects
- -Nausea, abdominal bloating and cramping
- -↑ LFTs
- -Myalgia

40
Q

what is the MOA of nicotinic acid?

A

1) Mechanism of action: inhibits lipolysis and fatty acid release in adipose tissue, decreases hepatic VLDL synthesis → ↓ triglyceride and LDL synthesis, ↑ HDL
2) Indication: high LDL cholesterol and lipoprotein(a) levels (> 50 mg/dL) despite statin and ezetimibe therapy (or if statins are contraindicated)
3) Side effects
- -Flushing and pruritus: ↑ prostaglandin synthesis → peripheral vasodilation
- -Pretreatment with aspirin or ibuprofen can minimize prostaglandin-mediated side effects
- -Paresthesias
- -GI upset (e.g., diarrhea, flatulence, abdominal pain)
- -↑ LFTs
- -Hyperglycemia
- -Hyperuricemia and gout (e.g., podagra)

41
Q

what is the ezetimibe?

A
  • -Mechanism of action: selective inhibition of cholesterol reabsorption at the brush border of enterocytes (cholesterol transporter NPC1L1) → ↓ LDL
  • -Indication
    1) Monotherapy: in contraindications or statin intolerance
    2) Combination therapy (statin and ezetimibe): in insufficient LDL cholesterol reduction by statins
42
Q

How PCSK9 inhibitors work?

A

1) Drugs: alirocumab, evolocumab
2) Mechanism of action: monoclonal antibodies that inhibit proprotein convertase subtisilin kexin 9 (PCSK9), an enzyme that degrades the LDL-receptor → increased removal of LDL from the blood stream → ↓↓↓ LDL, ↑ HDL, ↓ triglycerides
3) Side effects
- -Myalgia
- -Neurocognitive defects (delirum, dementia)